VH

Vyome Holdings, Inc.

HIND·NASDAQ

$5.73

+14%
HealthcareBiotechnology

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

At a Glance

Live Snapshot
Market Cap$151.09M
EPS-345.7400
P/E Ratio-1.29
Earnings Date05/18/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

VH

Vyome Holdings, Inc. Earnings Call Transcripts

HIND · NASDAQ